Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For ERYP.PA
Valuation Weak
14%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
17%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q3 Q4 Δ in %
Current Ratio 100.00 1.06 0.00
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 94.87 -0.24 -4.59
Naive Interpretation member
2 Per Share
Metric Q3 Q4 Δ in %
Book Value -47.57 3.90 7.43
Cash -68.82 1.59 5.11
Capex 100.00 0.02 0.00
Free Cash Flow -100.00 -1.93 0.00
Revenue 223.92 0.13 0.04
Naive Interpretation member
3 Profitability
Metric Q3 Q4 Δ in %
Gross Margin -55.11 0.45 1.00
Operating Margin 50.43 -14.47 -29.18
ROA -100.00 -0.22 0.00
ROE -183.72 -0.44 -0.16
ROIC -98.78 -0.31 -0.16
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of ERYP.PA is permitted for members.
5 Growth
The "Growth Entry" for the Focus of ERYP.PA is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of ERYP.PA is permitted for members.